Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CASP11 refinement experiments with ROSETTA.

Proteins·2015
Same author

Structure of a designed tetrahedral protein assembly variant engineered to have improved soluble expression.

Protein science : a publication of the Protein Society·2015
Same author

Unique double-ring structure of the peroxisomal Pex1/Pex6 ATPase complex revealed by cryo-electron microscopy.

Proceedings of the National Academy of Sciences of the United States of America·2015
Same author

Mechanistic Analysis of an Engineered Enzyme that Catalyzes the Formose Reaction.

Chembiochem : a European journal of chemical biology·2015
Same author

Design of ordered two-dimensional arrays mediated by noncovalent protein-protein interfaces.

Science (New York, N.Y.)·2015
Same author

Designing Two-Dimensional Protein Arrays through Fusion of Multimers and Interface Mutations.

Nano letters·2015

Related Experiment Video

Updated: Jun 22, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Blind docking of pharmaceutically relevant compounds using RosettaLigand.

Ian W Davis1, Kaushik Raha, Martha S Head

  • 1Department of Biochemistry, University of Washington, Seattle, Washington 98195-7350, USA.

Protein Science : a Publication of the Protein Society
|June 26, 2009
PubMed
Summary
This summary is machine-generated.

Validating molecular docking algorithms is challenging. Using private drug discovery data, RosettaLigand showed performance comparable to commercial programs, highlighting areas for improvement in docking protocols.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 22, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational biology
  • Drug discovery
  • Structural bioinformatics

Background:

  • Validating molecular docking algorithms using public data is limited due to known binding modes and unrepresentative test cases.
  • Public datasets may not accurately reflect the complexity of drug leads or novel compounds.
  • Accurate validation is crucial for reliable prediction of small molecule-protein interactions.

Purpose of the Study:

  • To perform a blind evaluation of the RosettaLigand docking methodology.
  • To compare RosettaLigand's performance against current commercial docking programs.
  • To identify areas for improvement in the RosettaLigand protocol using real-world drug discovery data.

Main Methods:

  • Utilized private data from a drug discovery program for a blind benchmark test.
  • Employed the Rosetta sampling methodology for simultaneous optimization of protein and ligand.
  • Evaluated RosettaLigand's ability to predict small molecule-protein binding modes.

Main Results:

  • RosettaLigand's performance was found to be comparable on average to leading commercial docking programs.
  • The study identified specific shortcomings in the RosettaLigand protocol.
  • The benchmark provided clear directions for future method development.

Conclusions:

  • RosettaLigand demonstrates competitive performance in molecular docking, particularly due to its integrated sampling approach.
  • Blind evaluation using private drug discovery data offers a more rigorous assessment of docking algorithms.
  • Further refinements to the RosettaLigand protocol can enhance its accuracy and applicability in drug discovery.